Calian Group (TSE:CGY) Given a C$106.00 Price Target by Ventum Capital Analysts

Key Points

• Ventum Capital set a C$106.00 price target on Calian Group and maintained a “buy” rating, implying 28.21% upside from the prior close.
• Analyst sentiment remains strongly positive: all 11 covering analysts rate the stock Buy, with a consensus rating of “Buy” and an average price target of C$101.95.
• Calian shares rose 0.6% to C$82.68, while the company recently reported C$1.10 quarterly EPS and C$230.40 million in revenue; insider Patrick Belanger Houston also purchased 699 shares.

Calian Group (TSE:CGY - Get Free Report) has been assigned a C$106.00 price objective by Ventum Capital in a research note issued on Thursday, BayStreet reports. The firm currently has a "buy" rating on the stock. Ventum Capital's price target points to a potential upside of 28.21% from the company's previous close.

Several other analysts also recently commented on CGY. Royal Bank Of Canada raised their price objective on Calian Group from C$90.00 to C$105.00 and gave the stock an "outperform" rating in a research note on Friday, August 14th. Ventum Financial set a C$106.00 price target on Calian Group and gave the stock a "buy" rating in a report on Thursday, August 27th. Desjardins raised their price target on Calian Group from C$104.00 to C$109.00 and gave the stock a "buy" rating in a research report on Friday, August 14th. Canaccord Genuity Group lifted their price objective on Calian Group from C$103.00 to C$105.00 and gave the company a "buy" rating in a report on Monday, June 29th. Finally, National Bank Financial set a C$100.00 price objective on Calian Group and gave the company an "outperform" rating in a research report on Tuesday. Eleven equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Calian Group has a consensus rating of "Buy" and an average price target of C$101.95.

Calian Group Trading Up 0.6%

TSE CGY traded up C$0.48 during trading on Thursday, reaching C$82.68. 25,967 shares of the stock traded hands, compared to its average volume of 41,792. Calian Group has a fifty-two week low of C$44.89 and a fifty-two week high of C$95.50. The company has a quick ratio of 1.20, a current ratio of 1.61 and a debt-to-equity ratio of 54.28. The firm has a market cap of C$952.72 million, a price-to-earnings ratio of 25.05, a price-to-earnings-growth ratio of 2.50 and a beta of 0.79. The stock's 50-day moving average price is C$79.67 and its 200 day moving average price is C$78.94.

Calian Group (TSE:CGY - Get Free Report) last posted its earnings results on Thursday, August 13th. The company reported C$1.10 earnings per share for the quarter. The company had revenue of C$230.40 million for the quarter. Calian Group had a net margin of 4.41% and a return on equity of 11.67%. Analysts predict that Calian Group will post 4.9475219 EPS for the current year.

Insider Buying and Selling

In related news, insider Patrick Belanger Houston purchased 699 shares of the stock in a transaction on Friday, August 28th. The shares were purchased at an average price of C$73.18 per share, with a total value of C$51,152.82. Following the transaction, the insider directly owned 22,965 shares of the company's stock, valued at C$1,680,578.70. This trade represents a 3.14% increase in their ownership of the stock. Company insiders own 0.63% of the company's stock.

Calian Group Company Profile

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.